{
  "@context": {
    "biotools": "https://bio.tools/ontology/",
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@id": "https://bio.tools/abm-tki",
  "@type": "sc:SoftwareApplication",
  "biotools:primaryContact": "Xiaoqiang Sun",
  "sc:additionalType": "Command-line tool",
  "sc:citation": "pubmed:22935054",
  "sc:description": "Employing agent-based model (ABM) tool to simulate brain tumor growth that includes an EGFR signaling pathway together with a related cell-cycle pathway, angiogenesis and tyrosine kinase inhibitors (TKIs) treatment. The users can apply this tool to predict the responses of brain cancer to TKIs, and to reveal the dual role of angiogenesis during TKI treatment.",
  "sc:name": "ABM-TKI",
  "sc:operatingSystem": [
    "Windows",
    "Mac",
    "Linux"
  ],
  "sc:url": "https://sites.google.com/site/agentbasedtumormodeling/home"
}